These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25512401)

  • 1. Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.
    Azzopardi EA; Ferguson EL; Thomas DW
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1837-43. PubMed ID: 25512401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.
    Cheah SE; Li J; Nation RL; Bulitta JB
    Antimicrob Agents Chemother; 2015 Jan; 59(1):381-8. PubMed ID: 25367905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextrin-colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections.
    Ferguson EL; Azzopardi E; Roberts JL; Walsh TR; Thomas DW
    Mol Pharm; 2014 Dec; 11(12):4437-47. PubMed ID: 25360900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.
    Tan CH; Li J; Nation RL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3413-5. PubMed ID: 17620384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Kroeger LA; Hovde LB; Mitropoulos IF; Schafer J; Rotschafer JC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3431-3. PubMed ID: 17576842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
    Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
    Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer Masked-Unmasked Protein Therapy: Identification of the Active Species after Amylase Activation of Dextrin-Colistin Conjugates.
    Varache M; Powell LC; Aarstad OA; Williams TL; Wenzel MN; Thomas DW; Ferguson EL
    Mol Pharm; 2019 Jul; 16(7):3199-3207. PubMed ID: 31125239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.
    Owen RJ; Li J; Nation RL; Spelman D
    J Antimicrob Chemother; 2007 Mar; 59(3):473-7. PubMed ID: 17289768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Evaluation of the Interaction of Dextrin-Colistin Conjugates with Bacterial Lipopolysaccharide.
    Roberts JL; Cattoz B; Schweins R; Beck K; Thomas DW; Griffiths PC; Ferguson EL
    J Med Chem; 2016 Jan; 59(2):647-54. PubMed ID: 26730548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
    Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
    J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
    Thamlikitkul V; Tiengrim S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
    Yadav R; Landersdorfer CB; Nation RL; Boyce JD; Bulitta JB
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2286-98. PubMed ID: 25645842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The colistin MIC determination in Acinetobacter baumannii, Should it be reviewed?].
    Villanueva X; Opazo-Capurro A; Quezada-Aguiluz M; Domínguez M; Bello-Toledo H; González-Rocha G
    Rev Chilena Infectol; 2017 Aug; 34(4):413-414. PubMed ID: 29165525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
    Ly NS; Bulitta JB; Rao GG; Landersdorfer CB; Holden PN; Forrest A; Bergen PJ; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2015 May; 70(5):1434-42. PubMed ID: 25712313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.